SARAH MILLS: Open Payments
NPI 1033195151 · BARBOURVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 19 payments from 12 companies in 2025. Trend: 2023 $383 · 2024 $424 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Incyte Corporation | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| ABBVIE INC. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Biogen, Inc. | 1 | $29 |
| EMD Serono, Inc. | 1 | $25 |
| ARRAY BIOPHARMA INC | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
Products named: KISQALI, JAKAFI, CAPLYTA, QULIPTA, KEYTRUDA, TYSABRI, PLUVICTO, LORBRENA.
Industry payments across KY — which companies pay providers there.
